Recent findings indicated that dDAVP is able to reduce tumor angiogenesis by inducing the formation of angiostatin (Ripoll et al. 2013), a naturally occurring inhibitor of angiogenesis generated by limited proteolysis of plasminogen. The gene discussed is PLG; the disease is neoplasm.